This month marks the 30th anniversary for the *American Journal of Respiratory Cell and Molecular Biology*. The *Red Journal* was created by the American Thoracic Society (then a part of the American Lung Association) in recognition of the rapidly expanding use of cellular and molecular approaches in the study of lung biology in health and disease. At that time, the leadership of the National Heart, Lung, and Blood Institute had been urging investigators of lung biology to focus more of their research on cellular and molecular mechanisms, and to incorporate more of the novel molecular tools that were becoming available. The American Thoracic Society created the *Red Journal* to provide a forum for disseminating this emerging body of work, which has grown remarkably in terms of volume and scientific sophistication since 1989.

Looking back, it is astounding how the science of lung cellular and molecular biology has changed since that time. When the *Red Journal* was created, the term "omics"---related to genetics, metabolism, proteins, and the microbiome---had not yet been coined. Progress in science is frequently driven by technical achievements resulting in new tools that allow investigators to push the frontiers of study forward. In that regard, the *Journal* has witnessed important achievements that have transformed the research landscape in biomedical science. For example, the Human Genome Project (2003) was the vanguard of genomic sequencing efforts that are now routinely used---directly or indirectly---by the majority of lung scientists. Similarly, advances in gene manipulation through the development of transgenic and gene knockout animals, the use of siRNA/shRNA constructs, and, more recently, CRISPR-Cas9 gene-editing technologies have provided researchers with powerful tools to explore the functional roles of specific genes in health and disease. These methods have also led to important methodological advances, such as the development of genomic screens that allow investigators to search the entire genome for individual genes that are required for a cellular response in a completely unbiased manner. In 1989 it was technically possible to amplify single (small) genes using PCR, but since then, techniques for quantifying the appearance of PCR products in real time have allowed investigators to measure relative levels of RNA signals in cells and tissues. The development of instruments that are capable of performing massively parallel gene sequencing operations has led to the emergence of next-generation sequencing. This technology has now become mainstream, allowing increasing numbers of laboratories to study the relative expression levels of the entire genome of an organism in cells or tissues. More recently, this technology has been advanced, allowing investigators to measure the transcriptome in thousands of cells in parallel (single-cell RNA sequencing). Robotic systems can now screen libraries containing many tens of thousands of small molecules (or just Food and Drug Administration--approved drugs) to identify novel candidates for the treatment of lung disorders. Other technical advances in instrument design have spurred the growth of metabolomics and proteomics, allowing scientists to measure known biomolecules, lipids, proteins, and protein post-translational changes in increasingly smaller sample sizes. These technical advances have swamped scientists with oceans of data, a challenge for which many were ill-prepared. This led to the emergence of the discipline of bioinformatics. Mathematicians in this field have developed computational and statistical tools to allow their research colleagues to extract meaning from datasets that would otherwise be incomprehensible. All of these advances have been made since the creation of the *Red Journal*, and virtually all have been reflected in the papers it has published since its inception.

Using these new tools, methods, and disciplines, respiratory cell and molecular biologists have made remarkable advances in understanding the biology related to lung development, the molecular basis for normal lung function, and the molecular mechanisms underlying acute and chronic lung diseases. Some of the most notable scientific achievements involve the linking of mutations in specific genes to disease pathogenesis in various disorders, including pulmonary vascular disease, interstitial lung disease, ciliary dysfunction, idiopathic pulmonary fibrosis, asthma, chronic obstructive pulmonary disease, emphysema, lung cancers, developmental disorders, surfactant disorders, acute lung injury, disorders of innate and adaptive immunity, and other lung diseases. Perhaps the best-known discovery is that mutations in CFTR (cystic fibrosis transmembrane conductance regulator) cause cystic fibrosis. That discovery led to the later identification of CFTR modulator drugs that are now transformative for patients with CF because they can potentiate, amplify, or correct protein defects that arise from certain CFTR mutations, and substantially alleviate the disease symptoms in the affected individuals. Single-cell analysis is now being applied to the developing lung to understand how the transcriptome of distinct cell types contributes to lung growth and maturation, and how lung diseases affect the molecular characteristics of existing and newly recruited cells in the lung. The list of accomplishments is long and growing, and the above examples represent a subset of all that has been accomplished. My apologies to all whose research areas are not included in the above examples!

The way we practice science has also changed dramatically during the lifetime of the *Journal*. In 1989, the World Wide Web was not yet available to the public, and internet service providers and e-mail did not become widely available until well into the 1990s. Researchers visited biomedical libraries in person with a photocopy card in hand, and PubMedCentral would not be launched until the *Journal* was celebrating its 11th year. Manuscript submissions went to journals as paper copies through the mail, and National Institutes of Health application Summary Statements arrived in the mail on pink paper. (Some veterans of those days still refer to them as "pink sheets."). How times have changed, and for the better!

So on this 30th anniversary of the *Red Journal*, I thank the many authors who have submitted their hard-earned research papers, review articles, perspectives, letters, and editorials---your work has made the *Journal* what it is today. I also wish to thank the many hundreds of scientists who have served the *Journal* by reviewing articles, and the many Editors-in-Chief and Deputy and Associate Editors who have set the "height of the bar" for the *Journal* in terms of scientific quality.

The mission of the *Red Journal* is to publish the best science related to pulmonary cellular, biochemical, molecular, developmental, genetic, and immunologic studies in health, and in acute and chronic disorders related to the respiratory system and sleep. Toward that goal, and in celebration of its success over the past 30 years, we are pleased to highlight two important emerging areas of lung research in this issue, related to "Single-Cell Approaches to Understanding Lung Biology" and "Lung Cell Senescence in Health and Disease." I predict that these areas will experience dramatic growth in the coming years. In the meantime, I urge you to submit your best work to the *Red Journal*, and recommend that you visit the *Journal* website (<https://www.atsjournals.org/journal/ajrcmb>) to enjoy some of the special features (podcasts, video summaries, and other highlights) that the *Journal* offers.
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